Tag Archives: incubators

Entrepreneurs

SEED SPOT hires Director of Entrepreneur Initiatives

Phoenix-based SEED SPOT, one of six incubators in the country focused on social entrepreneurs in the fields of health, education, energy and environment, human and basic rights, civic engagement, and community impact, hired C’pher Gresham as its Director of Entrepreneur Initiatives.

In his new role at SEED SPOT, Gresham will be responsible for enhancing programs, strengthening recruitment efforts, supporting funding development and guiding overall program growth strategy.

Hailing from the nation’s capital, Gresham attended The George Washington University, graduating with a BA in Psychology, Pre-Medicine, and a minor in Fine Arts and Art History. In May 2014, C’pher received his MBA with Distinction from Thunderbird School for Global Management.

Professionally, Gresham has consulted with venture capital firms, hedge funds, and large institutional investors. Prior to Thunderbird, he worked at Razoo.com, a crowdfunding platform for nonprofits and social enterprises. He has presented to the Arizona Tech Council and the Thunderbird Business Accelerator on how to leverage crowdfunding for early-stage for-profit and non-profit companies. Having worked with several startups and entrepreneurs, Gresham’s passion is spurring innovation, disrupting the market, and helping entrepreneurs.

bioscience

Bioscience Roadmap gets an extension through 2025

The strategic plan that has guided Arizona’s fast-growing bioscience sector for nearly 12 years is gearing up for a new decade.

“Arizona’s Bioscience Roadmap: 2014-2025” will be unveiled starting April 8 at events in Phoenix, Tucson, and Flagstaff, the state’s three metropolitan areas that feature growing bioscience hubs. The plan includes updated strategies that can strengthen and diversify Arizona’s economy while providing Arizonans access to the latest health care innovations.

“The updated Bioscience Roadmap builds on the successes of its first decade and adds contemporary strategies to take Arizona’s bioscience base to the next level,” said Jack Jewett, President & CEO of the Flinn Foundation, which commissioned the update and the original Bioscience Roadmap in 2002. “Arizona is now known as a top emerging bioscience state, but we have far to go to reach our full potential.”

The updated Roadmap will continue to focus on developing Arizona’s biomedical research infrastructure but will emphasize turning this research into new therapies, products, diagnostics, jobs, firms, and other benefits to Arizona. Commercialization, entrepreneurship, creating a critical mass of bioscience firms, and the development of talent are prime themes.

The Roadmap’s overarching vision is for Arizona—a young but rapidly growing state in the biosciences—to become a global competitor and national leader in select areas of the biosciences by 2025.

Over the first decade, Arizona built major research facilities at its universities, formed new private research institutes, attracted top talent, created high-tech business incubators, and greatly expanded statewide STEM (science, technology, education, math) education programs. The number of Arizona bioscience industry jobs grew by 45 percent, nearly four times greater than the nation.

“Arizona has many bioscience strengths and opportunities, but a substantial increase in private and public investment will be needed over the next decade to realize the Roadmap’s goals,” said Walter Plosila, senior advisor to the Battelle Technology Partnership Practice, the Columbus, Ohio-based nonprofit research and development organization that authored the original Roadmap and its update.

Plosila noted that Arizona’s greatest needs are access to risk capital by startup and emerging bioscience firms, building a stronger bioscience entrepreneurship culture, and an expansion of the research infrastructure combined with commercialization at the state’s universities.

The new Roadmap plan features five goals, 17 strategies, and 77 proposed actions. The actions are meant to evolve as needs change over the course of the decade. The plan was developed by Battelle following research, interviews, and focus groups with more than 150 local and national bioscience leaders, including extensive input from Arizona’s Bioscience Roadmap Steering Committee, a body of more than 100 statewide leaders in science, business, academia, and government.

“An emphasis on the full spectrum of the biosciences—from research to hospitals to bio-agriculture—and a renewed focus on resources, collaboration, and long-term patience is needed for Arizona to continue its ascent in the biosciences,” said Martin Shultz, Senior Policy Director for Brownstein Hyatt Farber Schreck, who chairs the Roadmap Steering Committee. “The impact can be profound—the biosciences are a multibillion-dollar industry for Arizona.”

There are six industry segments that comprise the biosciences in Arizona: agricultural feedstock and chemicals; drugs, pharmaceuticals, and diagnostics; medical devices and equipment; research, testing, and medical labs; bioscience-related distribution; and hospitals. A new economic-impact analysis by Battelle estimates the total revenue generated annually by Arizona’s bioscience industry—not counting hospitals—to be $14 billion. With hospitals included, the figure exceeds $36 billion.

Based on the latest industry data (2012), Arizona currently has 106,846 bioscience jobs spread across 1,382 establishments and an annual average wage of $62,775—39 percent higher than the private-sector average. These numbers do not include academic research jobs at the state universities or private research institutes.

Hospitals account for the majority of the state’s bioscience jobs. With hospitals removed from the equation, the other segments combine for 23,545 jobs, 1,266 establishments, and average annual wages of $85,571. Growth in the non-hospital segments accelerated dramatically over the last few years.

The bioscience-related distribution subsector is a new addition to Arizona’s bioscience definition, following the lead of the Biotechnology Industry Organization, the nation’s bioscience trade association. Companies in this subsector coordinate the delivery of bioscience-related products through processes such as cold storage and product monitoring, and new technologies such as automated pharmaceutical distribution systems. This change also called for several smaller industries to be dropped from Arizona’s definition.

The Roadmap also presents updated data on Arizona’s performance in generating grants from the National Institutes of Health, academic research expenditures, venture capital, and tech-transfer measures involving the state universities. These metrics plus industry measures will be tracked throughout the decade by Battelle and reported by the Flinn Foundation.

The Roadmap also includes analyses of Arizona’s bioscience sector that were critical in developing the strategies and actions, such as an assessment of Arizona’s bioscience strengths, weaknesses, opportunities, and challenges. It identified Arizona’s core competencies as cancer research, neurosciences, bioengineering, agricultural biotechnology, imaging sciences, precision medicine, diagnostics, health information technologies, and health economics.

The Flinn Foundation is a privately endowed, philanthropic grantmaking organization established in 1965 by Dr. Robert S. and Irene P. Flinn to improve the quality of life in Arizona to benefit future generations. The Phoenix-based foundation supports the advancement of the biosciences in Arizona, as well as a merit-based college scholarship program, arts and culture, and the Arizona Center for Civic Leadership. “Arizona’s Bioscience Roadmap: 2014-2025” is available for download at www.flinn.org.